House bill HR7640-117

Energy and Commerce Committee

To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").

• Last activity on May 03, 2022

• Introduced May 03, 2022

• By Rep. Bilirakis, Gus M. [R-FL-12]

Support this bill Share this bill
UnPac
12:45
Hi, welcome to UnPac!! ask me anything about UnPac and I'll try to help out. 😄